How much is Seelos Therapeutics stock worth?
One share of SEEL stock can currently be purchased for approximately $2.00. How much money does Seelos Therapeutics make? Seelos Therapeutics has a market capitalization of $204.63 million and generates $380,000.00 in revenue each year.
Where can I buy shares of Seel?
Shares of SEEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Should you pay close attention to Seelos (Seel) stock?
Investors need to pay close attention to Seelos (SEEL) stock based on the movements in the options market lately.
Where is Seelos Therapeutics located?
Seelos Therapeutics is headquartered at 300 PARK AVENUE 12TH FLOOR, NEW YORK NY, 10022. How can I contact Seelos Therapeutics? Seelos Therapeutics' mailing address is 300 PARK AVENUE 12TH FLOOR, NEW YORK NY, 10022. The company can be reached via phone at (646) 293-2100 or via email at anthony.marciano @seelostx.com.
Is SEEL stock a good buy?
The consensus among 2 Wall Street analysts covering (NASDAQ: SEEL) stock is to Strong Buy SEEL stock.
Will Seelos be delisted?
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 22, 2022 , Seelos Therapeutics, Inc....06/09Seelos Therapeutics Announces Data Demonstrating Statistically Significant...05/18Seelos Therapeutics Receives a Notice of Allowance in the U.S. for an...3 more rows•Apr 22, 2022
What does Seelos therapeutics do?
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare diseases.
Should I buy or sell Seelos Therapeutics stock right now?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Seelos Therapeutics in the last twelve months. There are currently 4 buy r...
What is Seelos Therapeutics' stock price forecast for 2022?
4 Wall Street research analysts have issued 12 month target prices for Seelos Therapeutics' shares. Their forecasts range from $4.00 to $8.00. On a...
How has Seelos Therapeutics' stock performed in 2022?
Seelos Therapeutics' stock was trading at $1.63 at the beginning of 2022. Since then, SEEL stock has decreased by 55.5% and is now trading at $0.72...
When is Seelos Therapeutics' next earnings date?
Seelos Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for Se...
Who are Seelos Therapeutics' key executives?
Seelos Therapeutics' management team includes the following people: Dr. Raj Mehra J.D. , Ph.D., Founder, Chairman, CEO & Pres (Age 62, Pay $921....
Who are some of Seelos Therapeutics' key competitors?
Some companies that are related to Seelos Therapeutics include CytoDyn (CYDY) , Aerovate Therapeutics (AVTE) , Akero Therapeutics (AKRO) , Lian...
What other stocks do shareholders of Seelos Therapeutics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Seelos Therapeutics investors own include VBI Vaccines (VB...
What is Seelos Therapeutics' stock symbol?
Seelos Therapeutics trades on the NASDAQ under the ticker symbol "SEEL."
Who are Seelos Therapeutics' major shareholders?
Seelos Therapeutics' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (5.96%...
About Seelos Therapeutics
Headlines
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders.
Seelos Therapeutics (NASDAQ:SEEL) Frequently Asked Questions
Could The Seelos Therapeutics, Inc. (NASDAQ:SEEL) Ownership Structure Tell Us Something Useful?